Announced Mon, 6 Jul · 14:54 IST
Promoter Jagdishkumar Ajudiya confirms no share encumbrance in FY26
Ownership Changes View source PDF
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹88.99
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.3-2.8+0.0-2.7+1.1-2.5-5.6———
Up moveDown movePending
AI summary
Promoter Jagdishkumar Devjibhai Ajudiya filed a yearly compliance disclosure under SEBI SAST Regulation 31(4) for Indo Us Biotech. He confirmed holding 1,36,93,643 shares, equal to 68.29 percent of the company as on March 31, 2026. He also stated that no encumbrance, pledge or similar charge was created on his shares during the financial year ended March 31, 2026.
Likely market impact
No change in promoter holding. No pledge or encumbrance created during FY26. Status quo confirmed for shareholders.